![](https://www.worldpharmaceuticals.net/wp-content/themes/goodlife-wp-B2B/images/WhitePaper_Default_icon.png)
A move towards a higher bioavailability of phytocannabinoids
By PharmaHemp
Dr Boštjan Jancar, CTO and head of R&D at PharmaHemp, explains the new products within phytocannabinoids, the differences between its liquid form and powder form, and how the company tackles enhancing bioavailability.
![](https://www.worldpharmaceuticals.net/wp-content/themes/goodlife-wp-B2B/images/WhitePaper_Default_icon.png)